CNR1 and arthritic joint disease: Recent studies have shown that the activation of CB1R by minor phytocannabinoids exerts anti-arthritis activity in murine models, highlighting its potential for the treatment of chronic inflammatory diseases such as rheumatoid arthritis (RA) [12].